Change In Working Capital - Cartesian Therapeutics Inc (NASDAQ:RNAC) - Alpha Spread

Cartesian Therapeutics Inc
NASDAQ:RNAC

Watchlist Manager
Cartesian Therapeutics Inc Logo
Cartesian Therapeutics Inc
NASDAQ:RNAC
Watchlist
Price: 16.54 USD 5.82% Market Closed
Market Cap: 353.6m USD
Have any thoughts about
Cartesian Therapeutics Inc?
Write Note

Cartesian Therapeutics Inc
Change in Working Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cartesian Therapeutics Inc
Change in Working Capital Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
Cartesian Therapeutics Inc
NASDAQ:RNAC
Change in Working Capital
-$42.4m
CAGR 3-Years
N/A
CAGR 5-Years
-61%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Change in Working Capital
-$49m
CAGR 3-Years
70%
CAGR 5-Years
49%
CAGR 10-Years
5%
Gilead Sciences Inc
NASDAQ:GILD
Change in Working Capital
-$4.1B
CAGR 3-Years
-20%
CAGR 5-Years
-28%
CAGR 10-Years
-13%
Amgen Inc
NASDAQ:AMGN
Change in Working Capital
-$1.4B
CAGR 3-Years
-10%
CAGR 5-Years
-26%
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Change in Working Capital
-$762.1m
CAGR 3-Years
-28%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Change in Working Capital
-$721.7m
CAGR 3-Years
45%
CAGR 5-Years
-15%
CAGR 10-Years
N/A

See Also

What is Cartesian Therapeutics Inc's Change in Working Capital?
Change in Working Capital
-42.4m USD

Based on the financial report for Jun 30, 2024, Cartesian Therapeutics Inc's Change in Working Capital amounts to -42.4m USD.

What is Cartesian Therapeutics Inc's Change in Working Capital growth rate?
Change in Working Capital CAGR 5Y
-61%

Back to Top